<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="23639">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on April 10, 2017</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02799043</url>
  </required_header>
  <id_info>
    <org_study_id>REDO-FIRM</org_study_id>
    <nct_id>NCT02799043</nct_id>
  </id_info>
  <brief_title>Randomized Evaluation of Redo Ablation Procedures of Atrial Fibrillation With Focal Impulse and Rotor Modulation Guided Procedures</brief_title>
  <acronym>REDO-FIRM</acronym>
  <official_title>Randomized Evaluation of Redo Ablation Procedures of Atrial Fibrillation With Focal Impulse and Rotor Modulation Guided Procedures (REDO-FIRM)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Abbott Electrophysiology</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Abbott Electrophysiology</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      A prospective, multicenter, randomized study to assess the safety and effectiveness of
      FIRM-guided procedures in conventional &quot;redo&quot; RF ablation procedures for the treatment of
      persistent and paroxysmal atrial fibrillation.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>June 2016</start_date>
  <completion_date type="Anticipated">March 2019</completion_date>
  <primary_completion_date type="Anticipated">December 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>Open Label</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Freedom from atrial fibrillation atrial fibrillation (AF), atrial tachycardia (AT), or atrial flutter (AFL) recurrence at 3 -12 months post procedure.</measure>
    <time_frame>3-12 months post treatment.</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Freedom from serious adverse events related to the procedure</measure>
    <time_frame>10-day post treatment.</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Freedom from serious adverse events related to the procedure</measure>
    <time_frame>12-month post treatment.</time_frame>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">268</enrollment>
  <condition>Persistent Atrial Fibrillation</condition>
  <condition>Paroxysmal Atrial Fibrillation</condition>
  <arm_group>
    <arm_group_label>Standard PVI</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Standard catheter ablation including pulmonary vein isolation (PVI) procedure.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>FIRM-guided Procedure and PVI</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>FIRM-guided procedure followed by PVI.</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Standard PVI</intervention_name>
    <description>Standard PVI procedure without FIRMap.</description>
    <arm_group_label>Standard PVI</arm_group_label>
    <other_name>Pulmonary vein isolation</other_name>
    <other_name>Ablation</other_name>
    <other_name>Arrhythmia</other_name>
    <other_name>Atrial fibrillation Mapping</other_name>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>FIRM-Guided Procedure and PVI</intervention_name>
    <arm_group_label>FIRM-guided Procedure and PVI</arm_group_label>
    <other_name>Pulmonary vein isolation</other_name>
    <other_name>Atrial fibrillation Mapping</other_name>
    <other_name>FIRMap</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Experiencing at least one (1) documented episode of spontaneous persistent or
             paroxysmal atrial fibrillation during the last 3 months by rhythm strip/ECG.

          -  One (1) previous AF ablation (PVI-only - any technology) in the last 2 years, but NOT
             within the last 3 months.

          -  Left atrial diameter &lt; 6.0 cm via transthoracic echo or transesophageal echo; or &lt;6.5
             cm via CT or MRI with 6 months prior to the procedure.

          -  Sustained spontaneous or induced AF (&gt;5 min uninterrupted).

          -  Confirmation of PV conduction.

        Exclusion Criteria:

          -  Presence of structural heart disease with clinical significance

          -  NYHA Class IV

          -  Ejection fraction &lt; 35%

          -  Previous AF ablation within the last 3 months

          -  ASD closure device, LAA closure device, prosthetic mitral or tricuspid valve, or
             permanent pacemaker.

          -  History of myocardial infarction (MI) within the past three (3) months

          -  Atrial clot/thrombus noted within 72 hours of the procedure
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Vivek Reddy, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Mount Sinai Hospital, New York</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Stefan G. Spitzer, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Praxisklinik Herz und Gefäße Dresden, Germany</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Andrea Quach</last_name>
    <phone>650-681-2047</phone>
    <email>andrea.quach@abbott.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Nirvi Mistry</last_name>
    <email>nirvi.mistry@abbott.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Arizona Heart Rhythm Research Cente</name>
      <address>
        <city>Phoenix</city>
        <state>Arizona</state>
        <zip>85016</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Sophie Raymond, MS</last_name>
    </contact>
    <investigator>
      <last_name>Dr. Vijendra Swarup, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Loyola University</name>
      <address>
        <city>Chicago</city>
        <state>Illinois</state>
        <zip>60153</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jean Del Priore, RN</last_name>
    </contact>
    <investigator>
      <last_name>David Wilber, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Indiana University, Krannert Institute of Cardiology</name>
      <address>
        <city>Indianapolis</city>
        <state>Indiana</state>
        <zip>46202</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Susan Straka, RN</last_name>
    </contact>
    <investigator>
      <last_name>John M Miller, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Mount Sinai Hospital</name>
      <address>
        <city>New York</city>
        <state>New York</state>
        <zip>10029</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Betsy A. Ellsworth, MSN, ANP</last_name>
    </contact>
    <investigator>
      <last_name>Subbarao Choudry, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Vivek Reddy, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Baylor Research Institute</name>
      <address>
        <city>Dallas</city>
        <state>Texas</state>
        <zip>75204</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Cathy Headley, RN</last_name>
    </contact>
    <investigator>
      <last_name>Robert C Kowal, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>STAR Clinical Trials,LLC</name>
      <address>
        <city>San Antonio</city>
        <state>Texas</state>
        <zip>78229</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Sandra McGriff, MS, CCRP</last_name>
    </contact>
    <investigator>
      <last_name>David N Pederson, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Heart and Diabetes Center North Rhine-Westphalia at Rhur Universtiy</name>
      <address>
        <city>Bad Oeynhausen</city>
        <state>North Rhine-Westphalia</state>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Anke Schmidt</last_name>
    </contact>
    <investigator>
      <last_name>George Nolker</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Ruhr University Bochum - Heart and Diabetes Center North Rhine-Westphalia</name>
      <address>
        <city>Bad Oeynhausen</city>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Kerstin Freese</last_name>
    </contact>
    <investigator>
      <last_name>George Nolker</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Praxisklinik Herz und Gefäße Dresden</name>
      <address>
        <city>Dresden</city>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Franziska Günther</last_name>
    </contact>
    <investigator>
      <last_name>Stefan G. Spitzer, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Germany</country>
    <country>United States</country>
  </location_countries>
  <verification_date>January 2017</verification_date>
  <lastchanged_date>January 4, 2017</lastchanged_date>
  <firstreceived_date>June 2, 2016</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>FIRMap, Rotor, FIRM-guided procedure</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Atrial Fibrillation</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
